116 related articles for article (PubMed ID: 1781885)
1. Active prorenin: evidence for the formation of a conformational variant of recombinant human prorenin.
Edalji R; Holzman TF; Gubbins EJ
J Protein Chem; 1991 Aug; 10(4):403-6. PubMed ID: 1781885
[TBL] [Abstract][Full Text] [Related]
2. New monoclonal antibodies directed against the propart segment of human prorenin as a tool for the exploration of prorenin conformation.
Cohen P; Simon D; Badouaille G; Mani JC; Portefaix JM; Pau B
J Immunol Methods; 1995 Jul; 184(1):91-100. PubMed ID: 7622873
[TBL] [Abstract][Full Text] [Related]
3. Similarity between physicochemical properties of recombinant rat prorenin and native inactive renin.
Hosoi M; Kim S; Yamauchi T; Watanabe T; Murakami K; Suzuki F; Takahashi A; Nakamura Y; Yamamoto K
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):727-31. PubMed ID: 2039449
[TBL] [Abstract][Full Text] [Related]
4. A structural model to explain the partial catalytic activity of human prorenin.
Heinrikson RL; Hui J; Zürcher-Neely H; Poorman RA
Am J Hypertens; 1989 May; 2(5 Pt 1):367-80. PubMed ID: 2655662
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human renin produced in different expression systems: biochemical properties and 3D structure.
Mathews S; Döbeli H; Pruschy M; Bosser R; D'Arcy A; Oefner C; Zulauf M; Gentz R; Breu V; Matile H; Schlaeger J; Fischli W
Protein Expr Purif; 1996 Feb; 7(1):81-91. PubMed ID: 9172787
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human prorenin from CHO cells: expression and purification.
Holzman TF; Chung CC; Edalji R; Egan DA; Gubbins EJ; Rueter A; Howard G; Yang LK; Pederson TM; Krafft GA
J Protein Chem; 1990 Dec; 9(6):663-72. PubMed ID: 1963533
[TBL] [Abstract][Full Text] [Related]
7. Identification of an enzyme in human kidney that correctly processes prorenin.
Shinagawa T; Do YS; Baxter JD; Carilli C; Schilling J; Hsueh WA
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1927-31. PubMed ID: 2408045
[TBL] [Abstract][Full Text] [Related]
8. Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor.
Morales R; Watier Y; Böcskei Z
J Mol Biol; 2012 Aug; 421(1):100-11. PubMed ID: 22575890
[TBL] [Abstract][Full Text] [Related]
9. Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody.
Derkx FH; Deinum J; Lipovski M; Verhaar M; Fischli W; Schalekamp MA
J Biol Chem; 1992 Nov; 267(32):22837-42. PubMed ID: 1429632
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of human prorenin isoelectric forms.
Su Y; Reudelhuber TL
J Hypertens; 1993 Feb; 11(2):141-6. PubMed ID: 8385173
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the oligosaccharide structures on recombinant human prorenin expressed in Chinese hamster ovary cells.
Aeed PA; Guido DM; Mathews WR; Elhammer AP
Biochemistry; 1992 Aug; 31(30):6951-61. PubMed ID: 1637829
[TBL] [Abstract][Full Text] [Related]
12. The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: studies with molecular chimeras.
Suzuki F; Nakagawa T; Kakidachi H; Murakami K; Inagami T; Nakamura Y
Biochem Biophys Res Commun; 2000 Jan; 267(2):577-80. PubMed ID: 10631104
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of human truncated prorenin.
Shinagawa T; Do YS; Baxter J; Hsueh WA
Biochemistry; 1992 Mar; 31(10):2758-64. PubMed ID: 1547216
[TBL] [Abstract][Full Text] [Related]
14. Non-proteolytic activation of human prorenin by anti-prorenin prosegment (pf#1: 1P-15P) antiserum.
Suzuki F; Hatano Y; Nakagawa T; Terazawa K; Gotoh A; Nasir UM; Ishida Y; Nakamura Y
Biosci Biotechnol Biochem; 1999 Mar; 63(3):550-4. PubMed ID: 10227141
[TBL] [Abstract][Full Text] [Related]
15. Protein modeling of human prorenin using the molecular dynamics method.
Shiratori Y; Nakagawa S; Hori H; Murakami K; Umeyama H
J Mol Graph; 1990 Sep; 8(3):163-7, 150. PubMed ID: 2279012
[TBL] [Abstract][Full Text] [Related]
16. Hydrolysis by plasma kallikrein of fluorogenic peptides derived from prorenin processing site.
Almeida PC; Chagas JR; Cezari MH; Juliano MA; Juliano L
Biochim Biophys Acta; 2000 Jun; 1479(1-2):83-90. PubMed ID: 11004531
[TBL] [Abstract][Full Text] [Related]
17. Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation.
Deinum J; Derkx FH; Schalekamp MA
Biochim Biophys Acta; 1998 Nov; 1388(2):386-96. PubMed ID: 9858773
[TBL] [Abstract][Full Text] [Related]
18. Human prorenin has "gate and handle" regions for its non-proteolytic activation.
Suzuki F; Hayakawa M; Nakagawa T; Nasir UM; Ebihara A; Iwasawa A; Ishida Y; Nakamura Y; Murakami K
J Biol Chem; 2003 Jun; 278(25):22217-22. PubMed ID: 12684512
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant human renin: kinetics, pH-stability, and peptidomimetic inhibitor binding.
Holzman TF; Chung CC; Edalji R; Egan DA; Martin M; Gubbins EJ; Krafft GA; Wang GT; Thomas AM; Rosenberg SH
J Protein Chem; 1991 Oct; 10(5):553-63. PubMed ID: 1799412
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant human prorenin and renin.
Carilli CT; Vigne JL; Wallace LC; Smith LM; Wong MA; Lewicki JA; Baxter JD
Hypertension; 1988 Jun; 11(6 Pt 2):713-6. PubMed ID: 3292415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
